HUTCHMED (China) (HUTCHMED (China)) Cash-to-Debt : 10.29 (As of Dec. 2023)

View and export this data going back to 2016. Start your Free Trial

What is HUTCHMED (China) Cash-to-Debt?

Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash, cash equivalents, and marketable securities divide by its debt. HUTCHMED (China)'s cash to debt ratio for the quarter that ended in Dec. 2023 was 10.29.

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. Here we can see, HUTCHMED (China) could pay off its debt using the cash in hand for the quarter that ended in Dec. 2023.

The historical rank and industry rank for HUTCHMED (China)'s Cash-to-Debt or its related term are showing as below:

HCM' s Cash-to-Debt Range Over the Past 10 Years
Min: 0.64 Med: 10.77 Max: 29.7
Current: 10.29

During the past 13 years, HUTCHMED (China)'s highest Cash to Debt Ratio was 29.70. The lowest was 0.64. And the median was 10.77.

HCM's Cash-to-Debt is ranked better than
76.72% of 1048 companies
in the Drug Manufacturers industry
Industry Median: 0.95 vs HCM: 10.29

HUTCHMED (China) Cash-to-Debt Historical Data

The historical data trend for HUTCHMED (China)'s Cash-to-Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

* Premium members only.

HUTCHMED (China) Cash-to-Debt Chart

HUTCHMED (China) Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Cash-to-Debt

Get a 7-Day Free Trial

6.56

13.22

29.70

23.36

10.29

HUTCHMED (China) Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Cash-to-Debt	Get a 7-Day Free Trial															29.70	1,976.56	23.36	21.33	10.29

Competitive Comparison of HUTCHMED (China)'s Cash-to-Debt

For the Drug Manufacturers - Specialty & Generic subindustry, HUTCHMED (China)'s Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

HUTCHMED (China)'s Cash-to-Debt Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, HUTCHMED (China)'s Cash-to-Debt distribution charts can be found below:

* The bar in red indicates where HUTCHMED (China)'s Cash-to-Debt falls into.

HUTCHMED (China) Cash-to-Debt Calculation

This is the ratio of a company's Cash, Cash Equivalents, Marketable Securities to its debt. The debt includes the Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation. This ratio measures the financial strength of a company. This ratio is updated quarterly.

HUTCHMED (China)'s Cash to Debt Ratio for the fiscal year that ended in Dec. 2023 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	886.336	/	(35.082	+	51.049)
	=	10.29

HUTCHMED (China)'s Cash to Debt Ratio for the quarter that ended in Dec. 2023 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	886.336	/	(35.082	+	51.049)
	=	10.29

HUTCHMED (China) (NAS:HCM) Cash-to-Debt Explanation

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.

HUTCHMED (China) Cash-to-Debt Related Terms

Thank you for viewing the detailed overview of HUTCHMED (China)'s Cash-to-Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

HUTCHMED (China) (HUTCHMED (China)) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » HUTCHMED (China) Ltd (NAS:HCM) » Definitions » Cash-to-Debt

Comparable Companies

Traded in Other Exchanges

00013:Hong Kong HCM.GB:UK HCM:UK H7T2:Germany

Address

2 Queen's Road Central, 48th Floor, Cheung Kong Center, Hong Kong, HKG

Website

https://www.hutch-med.com

HUTCHMED (China) Ltd is an innovative biopharmaceutical company engaged in the discovery, global development, and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. The company has a portfolio of several cancer drug candidates currently in clinical studies around the world and extensive commercial infrastructure in its home market of China. The company operates in two reportable segments Oncology/Immunology, and Other Ventures.